“The current set up for HS lesion counting in clinical trials and routine practice is far from ideal. Counting multiple lesions in multiple body sites takes time and there is high risk for error. Thalocan’s Lesion Area Mapping Assistant Trial enables sponsors to undertake quality control from the images and site personnel can assess images together to standardize their ratings and educate new lesion raters.” – Professor John Ingram, Cardiff UK

Professor John Ingram, along with Dr. Amit Garg, worked side by side with our Thalocan team in building LAMA, designed to overcome the time-consuming hurdles encountered in counting and assessment. In this video, Dr. Garg discusses and demonstrates how LAMA expedites the process along with improving both data quality and patient experience.